Streetbeat News

Regulatory

BTCUSD

SEC Chair Gary Gensler has indicated that following a court's order, the most sustainable course of action is to approve the listing and trading of spot ETP (Exchange-Traded Product) shares, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 9:46 pm

VTAK

Catheter Precision, Inc. (VTAK) released unaudited preliminary Q4 and FY23 results, reporting Q4 revenue of $129K and FY23 revenue of $442K. The company ended the year with $3.6 million in cash, total assets of $30.7 million, and shareholders' equity of $19.4 million. A significant net loss was reported for both Q4 and FY23, with a one-time $61 million write-off for goodwill impairment included in the annual loss. Key highlights include the launch of LockeT closure product in the US, expansion of sales and clinical personnel, and progress in clinical studies for LockeT. The company also received approval for its VIVO product in France and expanded its IP portfolio to 50 patents worldwide. CEO David Jenkins expressed optimism for 2024, citing momentum in product introductions and hospital evaluations. Final results are pending completion of year-end financial reporting and audit processes.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 9:45 pm

BTCUSD

The U.S. Securities and Exchange Commission (SEC) Chair has announced the approval of several spot Bitcoin exchange-traded products (ETPs) for listing.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 9:45 pm

NSTB

Northern Star Investment Corp. II (NSTB) received a noncompliance notice from the NYSE due to the resignation of two independent directors on December 19, 2023. Both directors were part of the audit committee, with one being financially sophisticated. Their resignations were not due to disagreements with the company's operations, policies, or practices.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 9:39 pm

ARKW

BITW

BTCUSD

GBTC

The SEC has approved applications for spot Bitcoin ETFs, a decision that is expected to significantly impact the cryptocurrency and traditional finance sectors. The approved ETFs include Grayscale Bitcoin Trust, Bitwise Bitcoin ETF, Hashdex Bitcoin ETF, iShares Bitcoin Trust, Valkyrie Bitcoin Fund, ARK 21Shares Bitcoin ETF, Invesco Galaxy Bitcoin ETF, VanEck Bitcoin Trust, WisdomTree Bitcoin Fund, Fidelity Wise Origin Bitcoin Fund, and Franklin Bitcoin ETF. This approval follows a false tweet from a compromised SEC account, which caused a temporary drop in Bitcoin prices. Experts predict the decision will attract new investors, integrate Bitcoin with traditional finance, and boost the digital asset ecosystem. The ETFs are seen as a step towards legitimizing Bitcoin and may lead to more stability and growth in the long term.

Portfolio Pulse from Murtuza Merchant

January 10, 2024 | 9:34 pm

BETS

Bit Brother Limited (NASDAQ:BETS) experienced a significant stock price movement on Wednesday, following the announcement of a 1-for-1,000 reverse stock split approved by its board. The split is expected to be effective around Jan. 10. Trading was halted on Tuesday night and resumed on Monday. Despite an initial drop of 15%, shares rose by nearly 30%. The volatility was partly due to market chaos linked to a compromised SEC Twitter account, which falsely claimed Bitcoin ETF approvals.

Portfolio Pulse from Ryan Gustafson

January 10, 2024 | 9:30 pm

GBTC

Grayscale Investments has received SEC approval to uplist its Grayscale Bitcoin Trust (GBTC) to NYSE Arca, making it one of the first spot Bitcoin ETFs in the U.S. GBTC, which holds 3.16% of all Bitcoin in circulation, will commence trading on NYSE Arca on January 11, 2024, and will cease trading on OTC Markets. The Trust plans to issue additional shares and employ creations and redemptions to closely track the value of its underlying Bitcoin holdings.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 9:29 pm

TTGT

Trading for TTGT was halted at 4:25:12 p.m. ET due to pending news. The halt is in place to manage market orderliness and investor protection pending the release of material news.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 9:25 pm

PLBY

PLBY Group received a letter from Nasdaq on January 10 confirming that the company has resolved its minimum bid price deficiency, as per a recent SEC filing.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 9:24 pm

ELUT

Elutia Pharmaceuticals has regained compliance with Nasdaq's requirements regarding the market value of listed securities and having a majority independent board. This follows previous non-compliance issues that put the company at risk of being delisted from the Nasdaq exchange. By addressing these issues, Elutia has avoided potential delisting and has reinforced its commitment to maintaining Nasdaq listing standards.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 9:06 pm